Cited 318 times in
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.